Skip to main content

Blood Transfusions in Obstetrics (Green-top Guideline No. 47)

Published: 01/12/2007

This is the first edition of this guideline. Minor amendments were made to the guideline in July 2008.

Update November 2014: This guideline is currently being revised, with publication anticipated late 2015. The version available on the website and app will remain valid until replaced.

Obstetric conditions associated with the need for blood transfusion may lead to morbidity and mortality if not managed correctly. The increasingly important issues in blood transfusion are adverse events associated with transfusion, including potential infection and potential transmission of prions, rising costs and the possible future problems of availability. Unfortunately, information from randomised controlled trials to inform best practice is largely unavailable in the discipline of blood transfusion.

This guideline provides advice about appropriate use of blood products. It is envisaged that this guideline will be incorporated into a protocol for each unit to disseminate locally.